Coming Soon! Breast Macrodissect AI
Reliable tumor content analysis for breast carcinoma specimens.
Coming Soon! Breast Macrodissect AI Read More »
Reliable tumor content analysis for breast carcinoma specimens.
Coming Soon! Breast Macrodissect AI Read More »
Reliable tumor content analysis for colorectal carcinoma specimens.
CRC Macrodissect AI Read More »
Reliable tumor content analysis for non-small cell lung cancer specimens.
Lung Macrodissect AI Read More »
AI-powered tools that quantify tumor content and guide ROI selection to enhance macrodissection workflows and downstream molecular analysis.
HALO Macrodissection Solutions Read More »
HALO AP Dx is an FDA-cleared case-centric pathology platform that enables primary diagnosis, remote working, and other routine workflows in anatomic pathology.
An automated, AI-based decision-support tool that standardizes scoring of HER2, ER, PR, and Ki67 IHC in breast cancer cases.
An automated, AI-based decision-support tool that standardizes the scoring of PD-L1 IHC in NSCLC cases.
An automated, AI-based tool for quality control of whole slide H&E- and IHC-stained images.
30 November 2023 | Learn how to implement Lung PD-L1 AI to assist PD-L1 scoring in non-small cell lung cancer
HALO AP is an AI-powered, pathologist-driven diagnostic pathology platform that brings together patient data, whole slide images, and AI-based decision support tools to enable remote working, primary diagnosis, and other routine workflows in anatomic pathology.